Heartflow, Inc. (NASDAQ:HTFL) Given Consensus Rating of “Moderate Buy” by Brokerages

Heartflow, Inc. (NASDAQ:HTFL) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, six have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $37.00.

HTFL has been the subject of several research analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a report on Thursday, March 19th. Wells Fargo & Company raised their price objective on shares of Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Canaccord Genuity Group dropped their price target on shares of Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research report on Friday, May 15th. Freedom Capital upgraded Heartflow to a “strong-buy” rating in a research note on Tuesday. Finally, William Blair started coverage on Heartflow in a research report on Monday, May 4th. They set an “outperform” rating on the stock.

Insider Buying and Selling

In related news, CEO John C.M. Farquhar sold 38,900 shares of Heartflow stock in a transaction that occurred on Wednesday, June 24th. The shares were sold at an average price of $35.00, for a total transaction of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares of the company’s stock, valued at approximately $16,027,725. The trade was a 7.83% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The stock was sold at an average price of $28.34, for a total transaction of $261,266.46. Following the transaction, the insider owned 78,731 shares of the company’s stock, valued at approximately $2,231,236.54. This represents a 10.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,115,805 shares of company stock worth $62,422,505 in the last ninety days. 7.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Heartflow

Institutional investors and hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP increased its stake in shares of Heartflow by 20.8% in the fourth quarter. Wellington Management Group LLP now owns 5,894,070 shares of the company’s stock valued at $171,812,000 after buying an additional 1,014,006 shares during the period. Bamco Inc. NY grew its holdings in Heartflow by 86.2% during the 4th quarter. Bamco Inc. NY now owns 2,303,877 shares of the company’s stock worth $67,158,000 after acquiring an additional 1,066,371 shares during the last quarter. Janus Henderson Group PLC grew its holdings in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after acquiring an additional 1,315,416 shares during the last quarter. Schusterman Interests LLC acquired a new position in Heartflow in the 3rd quarter valued at approximately $65,274,000. Finally, Capricorn Investment Group LLC bought a new position in shares of Heartflow during the fourth quarter valued at $48,178,000.

Heartflow Price Performance

Shares of NASDAQ:HTFL opened at $27.97 on Monday. The firm has a market cap of $2.41 billion and a price-to-earnings ratio of -8.99. Heartflow has a 12 month low of $20.13 and a 12 month high of $41.22. The company’s fifty day simple moving average is $30.56 and its 200 day simple moving average is $28.69.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.08. The company had revenue of $52.59 million for the quarter. The firm’s revenue was up 41.3% compared to the same quarter last year. Research analysts expect that Heartflow will post -0.82 earnings per share for the current fiscal year.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.